Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Sports Med Arthrosc Rev ; 30(1): 17-23, 2022 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-35113838

RESUMO

Postoperative infection remains a potentially devastating complication facing the sports medicine surgeon. Infection prevention begins with a thorough history and physical examination to identify patient specific risk factors and aid in risk stratification. Perioperative steroid injections should be used cautiously, with increased time prior to or following surgery being associated with lower infection risk. Sterile preparation with an alcohol containing solution is typically preferred, though there is limited evidence to identify which product is superior. Diagnosis can be challenging with a high index of suspicion needed to identify and appropriately manage patients. Treatment involves prompt irrigation and debridement with deep cultures. Antibiotic coverage should begin with empiric broad treatment and be tailored based on culture results. Early consultation with an infectious disease specialist is recommended to ensure appropriate antibiotic coverage and duration of treatment.


Assuntos
Doenças Transmissíveis , Medicina Esportiva , Cirurgiões , Desbridamento , Humanos , Complicações Pós-Operatórias
3.
Am J Sports Med ; 50(13): 3698-3704, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-34524032

RESUMO

BACKGROUND: Commercially available products used in knee cartilage reconstructive and restorative surgical practices fall under unique US Food and Drug Administration (FDA) regulatory pathways that determine the level of evidence required to market each product. PURPOSE: To evaluate the levels of evidence in the literature supporting commercially available cartilage repair procedures stratified by FDA regulatory pathway (section 351 vs section 361 of "Human Cells, Tissues, and Cellular and Tissue-Based Products" [HCT/P] in the Code of Federal Regulation) with the hypothesis that products requiring approval under a stringent regulatory pathway (351 HCT/P) have higher levels of evidence in the literature supporting use and that products with a less stringent regulatory pathway (361 HCT/P) have a higher number of products available for use in the United States. STUDY DESIGN: Systematic review; Level of evidence, 4. METHODS: A search of the PubMed database was performed to identify all peer-reviewed articles pertaining to either allograft or autologous cartilage repair technologies. Predefined inclusion and exclusion criteria were used to find clinical, preclinical, and laboratory studies while excluding duplicates, systematic reviews, and products not available in the United States. Articles were categorized by regulatory pathway (351 and 361 HCT/P), and variables including publication year, type of publication, level of evidence, and number of publications were analyzed. RESULTS: After application of predefined criteria, 470 of 1924 articles were included in this study. The 351 HCT/P group was composed entirely of autologous chondrocyte implantation (ACI) technology; 94% of the 361 HCT/P group was composed of osteochondral allografts (OCA). The articles regarding 351 HCT/P were more likely to be clinical in nature than the articles on 361 HCT/P (80% vs 48%, respectively; P = .0001) and entailed significantly more level 1 studies (25 vs 0, respectively; P < .0001). Twice as many articles in the 351 HCT/P group were published in the American Journal of Sports Medicine compared with the 361 HCT/P group (71 vs 38, respectively; P = .18). CONCLUSION: Both ACI and OCA have robust evidence supporting their use, whereas the remaining regulated products have little or no supporting evidence. Technologies regulated by 351 HCT/P were more likely to be level 1 clinical studies and published in the highest impact journal. The 361 HCT/P pathway regulated many more products, with fewer articles supporting their use.


Assuntos
Doenças das Cartilagens , Cartilagem Articular , Fraturas Intra-Articulares , Humanos , Estados Unidos , United States Food and Drug Administration , Cartilagem/transplante , Articulação do Joelho/cirurgia , Doenças das Cartilagens/cirurgia , Transplante Autólogo , Cartilagem Articular/cirurgia , Condrócitos/transplante
4.
Clin Sports Med ; 39(1): 165-183, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31767104

RESUMO

Meniscal injury potentiates a sequence of events that leads to degenerative changes and early osteoarthritis. It is therefore imperative to preserve the meniscus whenever possible. Given the expanding indications for meniscus repair, it is important to continually analyze and advance the understanding of rehabilitation and return to play following meniscal surgery. This article presents evidence-based rehabilitation and return-to-play guidelines as well as a brief review of return-to-play outcomes following isolated meniscus repair.


Assuntos
Volta ao Esporte , Lesões do Menisco Tibial/reabilitação , Lesões do Menisco Tibial/cirurgia , Humanos , Atrofia Muscular/terapia , Modalidades de Fisioterapia , Cuidados Pós-Operatórios , Músculo Quadríceps/irrigação sanguínea , Fluxo Sanguíneo Regional
5.
Arthrosc Tech ; 8(4): e407-e411, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31080724

RESUMO

Isolated rupture of the distal biceps femoris insertion is rare. Current literature offers limited case reports and outcome measures after surgical management. We describe a knotless suture anchor fixation technique for this tear pattern. At surgery, the retracted biceps tendon and insertion site is debrided to healthy tissue, FiberTape suture (Arthrex) is passed in a Kracków fashion through the tendon, and the 2 ends of the suture are brought down to a SwiveLock anchor (Arthrex) at the anatomic insertion. FiberWire sutures (Arthrex) from the anchor are brought over the remnant stump, completing the repair.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA